Barnett & Company, Inc. Bristol Myers Squibb CO Transaction History

Barnett & Company, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$61.48 - $73.72 $105,438 - $126,429	-1,715 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$53.63 - $62.52 $2,145 - $2,500	-40 Reduced 2.28%	1,715 $107,000
Q3 2021 Nov 04, 2021	SELL	$59.17 - $69.31 $6,153 - $7,208	-104 Reduced 5.59%	1,755 $104,000
Q2 2021 Jul 20, 2021	SELL	$61.91 - $67.42 $2,847 - $3,101	-46 Reduced 2.41%	1,859 $124,000
Q1 2021 Apr 19, 2021	SELL	$59.34 - $66.74 $17,802 - $20,022	-300 Reduced 13.61%	1,905 $120,000

Q2 2020 Jul 22, 2020	SELL	$54.82 - $64.09 $16,446 - $19,227	-300 Reduced 11.98%	2,205 $130,000
Q4 2019 Jan 22, 2020	BUY	$49.21 - $64.19 $123,271 - $160,795	2,505 New	2,505 $161,000

2,553

1.49B

25.9M

20M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $86B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Barnett & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Barnett & Company, Inc. with notifications on news.